MiniMed Group Inc. (MMED)
NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 19.18 +0.37%
MMED stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.38B
- Forward P/E
- 29.99
- EPS (TTM)
- -$1.53
- Dividend yield
- None
- 52-week range
- 10.65 – 24.43
- Day range
- 19.03 – 19.63
- Volume / Avg
- 9.62M / 2.35M
- Beta
- —
- Shares outstanding
- 281.35M
52-week range
MMED stock today
Shares of MiniMed Group (MMED) finished lower on Oct 7 at $19.11, a drop of 2.70% or $0.53 per share, versus the S&P 500's 0.22% decline. Volume was 4.1x the average at 9.62M shares, a sign of unusually heavy trading. Shares are 21.8% below their 52-week high of $24.43, set on Sep 2, 2026 and 79.4% above the 52-week low of $10.65, in the middle of the past year's range.
MiniMed Group has posted a net loss over the last twelve months (EPS of -$1.53), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About MiniMed Group
Company profileMiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Que Thanh Dallara
- Headquarters
- Northridge, CA
- Employees
- 8,000
- IPO year
- 2026
- Website
- minimed.com
Financial highlights
Full financialsIn fiscal 2026, MiniMed Group generated $3.10 billion in revenue, up 14.3% from fiscal 2025, its 2nd consecutive year of revenue growth. MiniMed Group reported a net loss of $333.0 million, compared with a loss of $213.0 million a year earlier. Gross margin was 54.2% (down from 56.3%) and operating margin -6.1%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Growth | +14.25% | +9.96% | — |
| Net income | $-333.00M | $-213.00M | $-112.00M |
| EPS (diluted) | $-1.30 | $-0.84 | $-0.44 |
Analyst forecast
ForecastConsensus (14 analysts)
buy
Avg. price target
$24.69+29.20%
- Strong buy 1
- Buy 10
- Hold 2
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Q1 2027)
- Sep 8, 2026
- EPS actual vs est.
- $0.00 vs —
MMED news
All MMED news- Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.PR NewswireMDT, MMED
- Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in OctoberNasdaqABBV, MDT, MMED
- DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes CareNasdaqDXCM, ABT, NVO, MMED
- MiniMed a new Buy at Truist on turnaround following Medtronic splitSeeking AlphaMDT, MMED
MiniMed Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STVNStevanato Group S.p.A. | 19.44 | -2.11% | $5.31B | vs MMED |
| TFXTeleflex Incorporated | 124.48 | -0.21% | $5.27B | vs MMED |
| MMSIMerit Medical Systems Inc. | 85.09 | +0.15% | $5.08B | vs MMED |
| HAEHaemonetics Corporation | 101.71 | -1.75% | $4.63B | vs MMED |
| HTFLHeartflow Inc. | 49.36 | -2.62% | $4.29B | vs MMED |
| ICUIICU Medical Inc. | 156.03 | -2.32% | $3.90B | vs MMED |
| NVSTEnvista Holdings Corporation | 23.04 | -0.99% | $3.70B | vs MMED |
| PLSEPulse Biosciences Inc | 49.09 | -1.33% | $3.50B | vs MMED |
Indexes, lists and sector
MiniMed Group stock FAQ
What is MiniMed Group's stock price today?
MMED last traded at $19.11 as of Oct 7, 4:00 PM EDT, down 2.70% on the day. Prices are delayed at least 15 minutes.
Who is MiniMed Group's CEO?
Ms. Que Thanh Dallara is the chief executive officer of MiniMed Group Inc., which has about 8,000 employees.
What is the MMED 52-week high?
The 52-week high for MMED is $24.43 and the 52-week low is $10.65. The stock is currently 21.8% below its high.